Skip to main content

Menu

Select a tool from the sidebar

Create your free account now!

Sign in to customize and use tools on the sidebar.

Sign InCreate free account
Moderna, Inc. logo
MRNA
Moderna, Inc.
20:00:01
63.96 $
0.0000 (%0.00)
Previous Close: 61.8
Day Low₺60.73
Day High₺67.74
Bid
Ask
Overview
Technicals
Financial Statements
Comments
Archive

MRNA: Moderna, Inc. Financials

Moderna, Inc. Income Statement

Total revenue
Net income
Gross margin TTM
55.35%
Operating margin TTM
-158.13%
Net profit margin TTM
-145.16%
Return on investment TTM
-32.62%
Period end31/12/202531/12/202431/12/202331/12/2022
Total revenue1,944,000,0003,199,000,0006,848,000,00018,875,000,000
Operating income-3,074,000,000-3,945,000,000-4,239,000,0009,420,000,000
Net income-2,822,000,000-3,561,000,000-4,714,000,0008,362,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Total revenue1,944,000,0003,199,000,0006,848,000,00018,875,000,000
Cost of revenue868,000,0001,464,000,0004,693,000,0005,416,000,000
Gross profit1,076,000,0001,735,000,0002,155,000,00013,459,000,000
Research and development expenses3,132,000,0004,543,000,0004,845,000,0003,295,000,000
General and administrative expenses01,028,000,0001,345,000,0001,011,000,000
Selling and marketing expenses0146,000,000204,000,000121,000,000
Selling, general and administrative expenses1,018,000,0001,174,000,0001,549,000,0001,132,000,000
Other expenses0-37,000,0000-388,000,000
Operating expenses4,150,000,0005,680,000,0006,394,000,0004,039,000,000
Cost and expenses5,018,000,0007,144,000,00011,087,000,0009,455,000,000
Net interest income304,000,000401,000,000383,000,000171,000,000
Interest income314,000,000425,000,000421,000,000200,000,000
Interest expense10,000,00024,000,00038,000,00029,000,000
Depreciation and amortization215,000,000189,000,000621,000,000348,000,000
EBITDA-2,553,000,000-3,394,000,000-3,283,000,0009,952,000,000
EBIT-2,768,000,000-3,583,000,000-3,904,000,0009,604,000,000
Non-operating income (excl. interest)-306,000,000-362,000,000-335,000,000-184,000,000
Operating income-3,074,000,000-3,945,000,000-4,239,000,0009,420,000,000
Total other income/expenses (net)306,000,000338,000,000297,000,000155,000,000
Income before tax-2,768,000,000-3,607,000,000-3,942,000,0009,575,000,000
Income tax expense54,000,000-46,000,000772,000,0001,213,000,000
Net income from continuing operations-2,822,000,000-3,561,000,000-4,714,000,0008,362,000,000
Net income from discontinued operations0000
Other adjustments to net income0000
Net income-2,822,000,000-3,561,000,000-4,714,000,0008,362,000,000
Net income deductions0000
Bottom line net income-2,822,000,000-3,561,000,000-4,714,000,0008,362,000,000
EPS-7-9-1221
Diluted EPS-7-9-1220
Weighted average shares outstanding389,000,000384,000,000382,000,000394,000,000
Weighted average diluted shares outstanding389,000,000384,000,000382,000,000416,000,000

Moderna, Inc. Balance Sheet

Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
1,243,000,000%
Total debt / assets MRQ
—
Period end31/12/202531/12/202431/12/202331/12/2022
Total assets12,338,000,00014,142,000,00018,426,000,00025,858,000,000
Total liabilities3,688,000,0003,241,000,0004,572,000,0006,735,000,000
Total equity8,650,000,00010,901,000,00013,854,000,00019,123,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Cash and cash equivalents2,595,000,0001,927,000,0002,907,000,0003,205,000,000
Short-term investments3,204,000,0005,098,000,0005,697,000,0006,697,000,000
Cash and short-term investments5,799,000,0007,025,000,0008,604,000,0009,902,000,000
Net receivables284,000,000592,000,0001,081,000,0001,685,000,000
Accounts receivable184,000,000358,000,000892,000,0001,385,000,000
Other receivables100,000,000234,000,000189,000,000300,000,000
Inventory153,000,000117,000,000202,000,000949,000,000
Prepaid expenses263,000,000307,000,000350,000,000851,000,000
Other current assets45,000,00058,000,00088,000,00044,000,000
Total current assets6,544,000,0008,099,000,00010,325,000,00013,431,000,000
Property, plant and equipment (net)2,853,000,0002,955,000,0002,658,000,0002,139,000,000
Goodwill52,000,00052,000,00052,000,0000
Intangible assets45,000,00040,000,00044,000,0000
Goodwill and intangible assets97,000,00092,000,00096,000,0000
Long-term investments2,342,000,0002,508,000,0004,743,000,0008,360,000,000
Tax assets81,000,00081,000,00081,000,000982,000,000
Other non-current assets421,000,000407,000,000523,000,000946,000,000
Total non-current assets5,794,000,0006,043,000,0008,101,000,00012,427,000,000
Other assets0000
Total assets12,338,000,00014,142,000,00018,426,000,00025,858,000,000
Total payables317,000,000408,000,000583,000,000535,000,000
Accounts payable317,000,000405,000,000520,000,000487,000,000
Other payables03,000,00063,000,00048,000,000
Accrued expenses0745,000,000997,000,0001,911,000,000
Short-term debt0000
Capital lease obligations (current)037,000,00025,000,000196,000,000
Tax payables03,000,00063,000,00048,000,000
Deferred revenue99,000,000153,000,000568,000,0002,038,000,000
Other current liabilities1,571,000,000863,000,000842,000,000243,000,000
Total current liabilities1,987,000,0002,206,000,0003,015,000,0004,923,000,000
Long-term debt1,243,000,000000
Capital lease obligations (non-current)673,000,000710,000,0001,218,000,0001,004,000,000
Deferred revenue (non-current)153,000,00058,000,00083,000,000673,000,000
Deferred tax liabilities (non-current)0000
Other non-current liabilities-368,000,000267,000,000256,000,000135,000,000
Total non-current liabilities1,701,000,0001,035,000,0001,557,000,0001,812,000,000
Other liabilities0000
Capital lease obligations673,000,000747,000,0001,243,000,0001,200,000,000
Total liabilities3,688,000,0003,241,000,0004,572,000,0006,735,000,000
Treasury stock0000
Preferred stock0000
Common stock0000
Retained earnings7,223,000,00010,045,000,00013,606,000,00018,320,000,000
Additional paid-in capital1,382,000,000866,000,000371,000,0001,173,000,000
Accumulated other comprehensive income/loss45,000,000-10,000,000-123,000,000-370,000,000
Other stockholders' equity0000
Total stockholders' equity8,650,000,00010,901,000,00013,854,000,00019,123,000,000
Total equity8,650,000,00010,901,000,00013,854,000,00019,123,000,000
Minority interest0000
Total liabilities and total equity12,338,000,00014,142,000,00018,426,000,00025,858,000,000
Total investments5,546,000,0007,606,000,00010,440,000,00015,057,000,000
Total debt1,916,000,000747,000,0001,243,000,0001,200,000,000
Net debt-679,000,000-1,180,000,000-1,664,000,000-2,005,000,000

Moderna, Inc. Cash Flow Statement

Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
Period end31/12/202531/12/202431/12/202331/12/2022
Cash from operations-1,873,000,000-3,004,000,000-3,118,000,0004,981,000,000
Cash from investing1,946,000,0001,949,000,0004,206,000,000-5,176,000,000
Cash from financing593,000,00056,000,000-1,377,000,000-3,448,000,000
Net change in cash668,000,000-999,000,000-289,000,000-3,643,000,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Net income-2,822,000,000-3,561,000,000-4,714,000,0008,362,000,000
Depreciation and amortization215,000,000189,000,000621,000,000348,000,000
Deferred income tax00828,000,000-559,000,000
Stock-based compensation483,000,000429,000,000305,000,000226,000,000
Change in working capital254,000,000-78,000,000-139,000,000-3,455,000,000
Accounts receivable156,000,000534,000,000493,000,0001,790,000,000
Inventory-34,000,00083,000,000747,000,000492,000,000
Accounts payable-92,000,000-69,000,00013,000,000240,000,000
Other working capital224,000,000-626,000,000-1,392,000,000-5,977,000,000
Other non-cash items-3,000,00017,000,000-19,000,00059,000,000
Net cash from operating activities-1,873,000,000-3,004,000,000-3,118,000,0004,981,000,000
Investments in property, plant and equipment-192,000,000-1,051,000,000-707,000,000-400,000,000
Acquisitions (net)00-85,000,0000
Purchases of investments-5,768,000,000-6,529,000,000-3,783,000,000-11,435,000,000
Sales/maturities of investments7,916,000,0009,529,000,0008,781,000,0006,699,000,000
Other investing activities-10,000,00000-40,000,000
Net cash from investing activities1,946,000,0001,949,000,0004,206,000,000-5,176,000,000
Net debt issuance539,000,000-10,000,000-270,000,000-184,000,000
Long-term net debt issuance560,000,000-10,000,000-270,000,000-184,000,000
Short-term net debt issuance-21,000,000000
Net stock issuance35,000,00066,000,000-1,107,000,000-3,264,000,000
Net common stock issuance35,000,00066,000,000-1,107,000,000-3,264,000,000
Common stock issuance35,000,00066,000,00046,000,00065,000,000
Common stock repurchased00-1,153,000,000-3,329,000,000
Net preferred stock issuance0000
Net dividends paid0000
Common dividends paid0000
Preferred dividends paid0000
Other financing activities19,000,000000
Net cash from financing activities593,000,00056,000,000-1,377,000,000-3,448,000,000
Effect of FX changes on cash2,000,000000
Net change in cash668,000,000-999,000,000-289,000,000-3,643,000,000
Cash at end of period2,597,000,0001,929,000,0002,928,000,0003,217,000,000
Cash at beginning of period1,929,000,0002,928,000,0003,217,000,0006,860,000,000
Operating cash flow-1,873,000,000-3,004,000,000-3,118,000,0004,981,000,000
Capital expenditure-192,000,000-1,051,000,000-707,000,000-400,000,000
Free cash flow-2,065,000,000-4,055,000,000-3,825,000,0004,581,000,000
Income taxes paid0197,000,00002,729,000,000
Interest paid024,000,00039,000,00025,000,000